Marissa D. Zwan

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn et al. · Alzheimer s Research & Therapy · 2020 · 273 citations · Full text

Medicine, Neurology, Neuroscience +17

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1–42 Analysis Results

Betty M. Tijms, Eline A.J. Willemse, Marissa D. Zwan et al. · Clinical Chemistry · 2017 · 254 citations · Full text

Medicine, Biostatistics, Neurology +17

Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231

Sherif Bayoumy, Inge M.W. Verberk, Ben den Dulk et al. · Alzheimer s Research & Therapy · 2021 · 197 citations · Full text

Medicine, Geriatric Medicine, Dementia +13

Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort

Arno de Wilde, Wiesje M. van der Flier, Wiesje Pelkmans et al. · JAMA Neurology · 2018 · 165 citations · Full text

Medicine, Neurology, Neuroscience +17

Concordance Between Cerebrospinal Fluid Biomarkers and [11C]PIB PET in a Memory Clinic Cohort

Marissa D. Zwan, Argonde C. van Harten, Rik Ossenkoppele et al. · Journal of Alzheimer s Disease · 2014 · 125 citations

Medicine, Neurology, Neuroscience +17